U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H18F3N3O3
Molecular Weight 369.3383
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RU-58841

SMILES

CC1(C)N(CCCCO)C(=O)N(C1=O)C2=CC(=C(C=C2)C#N)C(F)(F)F

InChI

InChIKey=ARBYGDBJECGMGA-UHFFFAOYSA-N
InChI=1S/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C17H18F3N3O3
Molecular Weight 369.3383
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9415227 | https://www.ncbi.nlm.nih.gov/pubmed/9798729 | https://www.ncbi.nlm.nih.gov/pubmed/7625751 | https://www.ncbi.nlm.nih.gov/pubmed/9449168 | http://adisinsight.springer.com/drugs/800005990

RU58841 is a topically active non-steroidal antiandrogen. It demonstrated efficacy in animal models of androgen-dependent skin disorders such as acne and androgenetic alopecia. Under name of PSK 3841 was being developed by ProStrakan. It underwent clinical evaluation for the treatment of androgen-dependent conditions, such as acne and alopecia. Following the conclusion of phase II trials, no further development was reported. Based on this and the fact the compound is not listed on the companies pipeline, development is presumed discontinued.

Originator

Approval Year

Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
1994 Jan
Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: relation of their systemic activity to the formation of a common metabolite.
1994 Oct
Local inhibition of sebaceous gland growth by topically applied RU 58841.
1995 Jun 12
Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats.
1997
Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes.
1997 May
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.
1997 Nov
Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.
1998 Aug
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
2005 Jan
Patents

Patents

Sample Use Guides

Mice: topically (5 days/week) with RU58841 1% in ethanol. Stumptailed macaques: the topical application of RU58841 (a 5% solution in a propyleneglycol and isopropanol mixture).
Route of Administration: Transdermal
In Vitro Use Guide
RU58841 do not enhance androgen receptor transcriptional activity at 10 pM - 0.1 uM in PC3 cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:32:24 UTC 2023
Edited
by admin
on Fri Dec 15 15:32:24 UTC 2023
Record UNII
0D8FJQ0ADW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RU-58841
Code English
4-(3-(4-HYDROXYBUTYL)-4,4-DIMETHYL-2,5-DIOXO-1-IMIDAZOLINDYL)-2-(TRIFLUOROMETHYL)-BENZONITRILE
Common Name English
4-(4,4-DIMETHYL-2,5-DIOXO-3-(4-HYDROXYBUTYL)1-IMIDAZOLIDINYL)-2-(TRIFLUOROMETHYL)BENZONITRILE
Systematic Name English
BENZONITRILE, 4-(3-(4-HYDROXYBUTYL)-4,4-DIMETHYL-2,5-DIOXO-1-IMIDAZOLIDINYL)-2-(TRIFLUOROMETHYL)-
Systematic Name English
4-(3-(4-HYDROXYBUTYL)-4,4-DIMETHYL-2,5-DIOXO-1-IMIDAZOLIDINYL)-2-TRIFLUOROMETHYLBENZONITRILE
Systematic Name English
Code System Code Type Description
PUBCHEM
132981
Created by admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
PRIMARY
EPA CompTox
DTXSID20165781
Created by admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
PRIMARY
CAS
154992-24-2
Created by admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
PRIMARY
WIKIPEDIA
RU-58841
Created by admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
PRIMARY
FDA UNII
0D8FJQ0ADW
Created by admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
PRIMARY
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
IN-VIVO